Format

Send to

Choose Destination
See comment in PubMed Commons below
Front Biosci (Schol Ed). 2010 Jan 1;2:571-7.

Clinical biomarkers in hepatocellular carcinoma (HCC).

Author information

1
Surgical Sciences, Organ Transplantations and New Technologies Department, General and Week Surgery OU University Hospital of Catania, Via S Sofia No 78, 95125 Catania, Italy. mar_donati@yahoo.it

Abstract

The Authors make a review of the most important molecules used today for detecting and screening hepatocellular carcinoma, analyzing their known biological features, advantages and limits especially concerning differential diagnosis from cirrhosis and others diseases. AFP, AFP-L3, DCP, Alpha-1-fucosidase are analyzed and all the current knowledge reviewed, as well as focusing on possible future applications and results of combined determination (what about another word here: evaluation etc) in HCC. Additionally other more recent molecules showing promising future clinical application are cited.

PMID:
20036969
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontiers in Bioscience
    Loading ...
    Support Center